Activities of daily living, behavioral and psychological symptoms of dementia, and cognitive and physical function according to thyroid function in Alzheimer's disease

View at publisher
Authors: Chisato Fujisawa, Haruki Fujisawa, Yosuke Matsui, Taiki Sugimoto, Miki Minakami, Kazuhisa Watanabe, Yosuke Yamada, Hirotaka Nakashima, Hitoshi Komiya, Yoshihisa Sugimura, Hiroyuki Umegaki, Takashi Sakurai
Cited by: 1
References: 60

Abstract

BackgroundThe relationships between thyroid hormone profiles and activities of daily living (ADLs), behavioral and psychological symptoms (BPSD), cognitive status, and physical function in patients with Alzheimer's disease (AD) remain poorly understood.ObjectiveThis study investigates the relationships among ADLs, BPSD, and cognitive and physical function relative to thyroid status in patients with AD.MethodsWe recruited 2484 outpatients diagnosed with AD aged 65 and older with serum free triiodothyronine (FT3), free thyroxine (FT4), and thyroid-stimulating hormone (TSH) levels measured at their first memory clinic visit. The participants were divided into five groups by their serum FT4 and TSH levels: euthyroidism, hypothyroidism, subclinical hypothyroidism, hyperthyroidism, and subclinical hyperthyroidism. Differences in dependent variables among these groups were compared using analysis of covariance. Correlations of the dependent variables with FT3, FT4, FT3/FT4, and TSH levels and the presence of non-thyroidal illness syndrome (NTIS) were examined using a multiple regression model.ResultsNo significant differences in ADLs, BPSD, and cognitive or physical performance were observed among the groups stratified by FT4 and TSH levels. Although there were slight variations according to the analytical method employed, the overall results indicated that lower FT3, higher FT4, and lower FT3/FT4 were correlated with worse ADLs, mood, and cognitive and physical function. AD patients with NTIS exhibited notably worse basic ADLs than other groups.ConclusionsThese results suggest that thyroid hormone levels are associated with ADLs, mood, and cognitive and physical function in AD patients, suggesting the need for careful monitoring of AD patients with lower FT3, higher FT4, lower FT3/FT4, and NTIS.

Fields of Study & Subjects

Thyroid Disorders and Treatments Thyroid Cancer Diagnosis and Treatment Dementia and Cognitive Impairment Research

Publication details

Journal / source
Journal of Alzheimer s Disease
Publisher
SAGE Publications
Volume
110
Issue
3
Pages
1447–1457
Publication date
24 February 2026
Language
EN